 Patent Scorecard ranks Wyeth (Madison, NJ, 

) first among 35 global  pharmaceutical companies evaluated for patent-based intellectual property (IP).  Pfizer, Inc. (New York, NY, 

)  took the second position and Johnson & Johnson (New Brunswick, NJ, 

) was ranked third, with  Bristol-Myers Squib (New York, NY, 

)  following close behind at numbers four and five.

  The indicators used for measuring patent-based IP included  patents granted; quality of patents; science strength, or the degree to which a  company’s patent portfolio is linked to core science; research intensity, a  comparative measure of the level of basic research; and innovation cycle time.

BioBusiness

Intellectual Property & Patents

News

The August 7, 2007, issue of The Wall Street Journal Patent Scorecard ranks Wyeth (Madison, NJ, www.wyeth.com) first among 35 global pharmaceutical companies evaluated for patent-based intellectual property (IP).